|

Group 1: DSL101 Low dose Clinical Trials

1 actively recruiting trial

Pipeline

Early 1: 1

Top Sponsors

  • DSciLab Co., Ltd.1

Indications

  • Wilsons Disease1
  • Liver Disease1

Other1 trial

A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.